Dr. David L. Cooper, PhD, MD, Medosi Medical Advisor, publishes: Primer: CBD toxicity and potential drug-drug interactions for Medosi’s Corporate clients and customers.
Dr Cooper reviews Medosi’s natural hemp cannabinoids vs. synthetic and biological pharmaceuticals for safety and efficacy.
Included is a detailed look at the Therapetuic Ratio and Safety Comparison of Cannabis to common OTC and prescription drugs.
Dr Cooper is also the Founder and CEO of PhytoDental Solutions LLC. He was invited to join Medosi Corporation Medical Advisory Board, Louisville, KY in May 2020.